<DOC>
	<DOCNO>NCT00437827</DOCNO>
	<brief_summary>This study test process ( rEEG ) select appropriate medication ( ) treat patient 's depression versus control group treat accord standardized method , modify Star*D Algorithm . Qualified subject randomize experimental ( rEEG guide ) group , control group treat 12 week . Medications utilized study currently market . All visit , physical exam , rEEG , lab , rating scale medication provide cost patient .</brief_summary>
	<brief_title>rEEG Guided Pharmacotherapy Subjects With Depression Treatment Failure</brief_title>
	<detailed_description>This study test process ( rEEG ) select appropriate medication ( ) treat patient 's depression versus control group treat accord standardized method , modify Star*D Algorithm . Qualified subject randomize experimental ( rEEG guide ) group , control group treat 10 week . Medications utilized study currently market . All visit , physical exam , rEEG , lab , rating scale medication provide cost patient . To qualify entry study , patient must : 1 . 18 year age old . 2 . Diagnosis Major Depressive Disorder . Subjects may meet criterion melancholic atypical depression . 3 . Have fail 1 SSRIs , fail 2 antidepressant least 2 drug class . And patient must : 1 . History : closed head injury unconsciousness , craniotomy , cerebral metastasis , cerebrovascular accident ; current diagnosis seizure disorder , bipolar disorder , schizophrenia , dementia , mental retardation , substance abuse , major depression psychotic feature ; use depot neuroleptic last 12 month . 2 . Known pregnancy and/or lactation , intent become pregnant study . Medications use study : Anti-depressants : fluoxetine , sertraline , paroxetine , desipramine , imipramine , nortriptyline , amitriptyline , clomipramine , bupropion , venlafaxine Stimulants &amp; MAO Inhibitors : moclobemide , tranylcypromine , selegiline , methylphenidate , dextroamphetamine , dexlevoamphetamine , pemoline , lamotrigine , topiramate Benzodiazepines : lorazepam , clonazepam , alprazolam Anti-convulsants : carbamazepine , lithium , divalproex , gabapentin Beta Blockers : metoprolol , propranolol , atenolol</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>1 . 18 year age old . 2 . Diagnosis Major Depressive Disorder validate SCID . Subjects may meet criterion melancholic atypical depression per protocol . 3 . Have fail three antidepressant regimen current depressive episode minimum daily dose ( ) define Medication History Depression Case Report Form minimum duration treatment least 4 week . For purpose Study , augmentation consider separate regimen . 4 . Able stop medication 5 halflives medication ( ) , exception hormone , thyroid , hydrochlorthiazide Ambien . See Appendix II list halflives medication . 1 . History : closed head injury unconsciousness , craniotomy , cerebral metastasis , cerebrovascular accident ; current diagnosis seizure disorder , bipolar disorder , schizophrenia , dementia , mental retardation , substance abuse , major depression psychotic feature ; use depot neuroleptic last 12 month . 2 . Participation therapeutic drug study evaluate treatment depression within 60 day precede inclusion , unless drug ( ) halflife know . 3 . Known pregnancy and/or lactation , intent become pregnant study . 4 . Does n't qualify via rEEG analysis due : Potential physiologic abnormality Low abnormality comparison current rEEG database No strong prediction rEEG analysis particular medication class</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Depression</keyword>
</DOC>